Learn how Cubresa’s customers are using the power of NuPET technology to enhance their research in a variety of application areas.
PET/MRI evaluation of white matter inflammation in a co-morbid rat model of ischemic stroke and Alzheimer’s disease (and others)
The application of simultaneous PET/MRI in preclinical cancer research, focusing on the study of novel cancer immunotherapies.
Our research program is investigating three developments of simultaneous PET/MRI with pre-clinical tumor models.
Tracking CAR T cell therapies with PET/MRI
Evaluations of oxidative phosphorylation and glycolysis metabolism in tumors using PET/MRI
Combining [F18]FAZA PET and DCE MRI to evaluate anti-cancer drug treatments
Comparisons of hyperpolarized MR and FDG PET for assessments of pancreatic cancer treatment with antiandrogen drug therapy
Development of Applications of PET/MR
Cubresa is a world leader in the design and development of clinical and preclinical PET inserts for MRI. Cubresa products enable medical professionals at leading universities, hospitals and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.
Company
About Us
Leadership
Technology
Careers
Location
Cubresa Inc.
800-136 Market Ave
Winnipeg, MB, Canada
R3B 0P4
Products
Clinical:
Preclinical:
Contact
Request more information